Evaluation of a cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery disease.

Kevin F Fox, David A Wood, Melissa Wright, Sharon Bond, Michaela Nuttall, Barbara Arora, Ellen Dawson, Patricia Devane, Steven J Sutcliffe, Ken Brown
{"title":"Evaluation of a cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery disease.","authors":"Kevin F Fox,&nbsp;David A Wood,&nbsp;Melissa Wright,&nbsp;Sharon Bond,&nbsp;Michaela Nuttall,&nbsp;Barbara Arora,&nbsp;Ellen Dawson,&nbsp;Patricia Devane,&nbsp;Steven J Sutcliffe,&nbsp;Ken Brown","doi":"10.1097/01.hjr.0000049245.21319.69","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A cardiac prevention and rehabilitation (CP&R) programme was established for patients following their first clinical episode of coronary heart disease and 1-year outcomes were evaluated against British targets for coronary prevention.</p><p><strong>Methods: </strong>Patients were evaluated 1 year after participation and outcomes compared with patients in the same health district registered with a random half of general practitioners not eligible for the programme (internal reference group) and patients identified in other English centres which participated in the EUROASPIRE II survey (external reference group).</p><p><strong>Results: </strong>Three hundred and eighteen patients (76% of 417 incident cases) attended for 1-year screening. Of those who participated in the programme 96/113 (85%) attended (Group 1); 152/194 (78%) attended from all those eligible for the programme (Group 2); 166/223 (74%) attended from those receiving usual care in the same health district (Group 3 - internal reference group). In the EUROASPIRE II survey (Group 4 - external reference group) 362/744 (58%) patients were screened. Current smoking at follow-up was Group 1, 8%, Group 2, 11%, Group 3, 13% and Group 4, 18%. Proportions with a BMI < 25 kg/m were 29%, 25%, 32%, 18%; BP < 140/90 mmHg 58%, 56%, 49%, 48%; total cholesterol < 5.0 mmol/l 60%, 54%, 43%, 46%; antiplatelet therapy 88%, 87%, 86%, 81%; beta-blocker therapy 48%, 46%, 46%, 44%; and lipid lowering therapy 56%, 51%, 36%, 69% respectively.</p><p><strong>Conclusions: </strong>A CP&R programme was associated with a majority of coronary patients, whether attending the programme or not, achieving the Joint British Society's recommended prevention targets within the same health district. Specifically, a higher proportion of programme patients reached the cholesterol target of <5.0 mmol/l compared with both usual care and other centres elsewhere. This was achieved by using more lipid lowering therapy compared with usual care in the same health district, but less than other centres outside the health district. The overall results for the whole health district show a higher standard of preventive care compared with contemporary EUROASPIRE II results from other health districts in England.</p>","PeriodicalId":79345,"journal":{"name":"Journal of cardiovascular risk","volume":"9 6","pages":"355-9"},"PeriodicalIF":0.0000,"publicationDate":"2002-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiovascular risk","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.hjr.0000049245.21319.69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A cardiac prevention and rehabilitation (CP&R) programme was established for patients following their first clinical episode of coronary heart disease and 1-year outcomes were evaluated against British targets for coronary prevention.

Methods: Patients were evaluated 1 year after participation and outcomes compared with patients in the same health district registered with a random half of general practitioners not eligible for the programme (internal reference group) and patients identified in other English centres which participated in the EUROASPIRE II survey (external reference group).

Results: Three hundred and eighteen patients (76% of 417 incident cases) attended for 1-year screening. Of those who participated in the programme 96/113 (85%) attended (Group 1); 152/194 (78%) attended from all those eligible for the programme (Group 2); 166/223 (74%) attended from those receiving usual care in the same health district (Group 3 - internal reference group). In the EUROASPIRE II survey (Group 4 - external reference group) 362/744 (58%) patients were screened. Current smoking at follow-up was Group 1, 8%, Group 2, 11%, Group 3, 13% and Group 4, 18%. Proportions with a BMI < 25 kg/m were 29%, 25%, 32%, 18%; BP < 140/90 mmHg 58%, 56%, 49%, 48%; total cholesterol < 5.0 mmol/l 60%, 54%, 43%, 46%; antiplatelet therapy 88%, 87%, 86%, 81%; beta-blocker therapy 48%, 46%, 46%, 44%; and lipid lowering therapy 56%, 51%, 36%, 69% respectively.

Conclusions: A CP&R programme was associated with a majority of coronary patients, whether attending the programme or not, achieving the Joint British Society's recommended prevention targets within the same health district. Specifically, a higher proportion of programme patients reached the cholesterol target of <5.0 mmol/l compared with both usual care and other centres elsewhere. This was achieved by using more lipid lowering therapy compared with usual care in the same health district, but less than other centres outside the health district. The overall results for the whole health district show a higher standard of preventive care compared with contemporary EUROASPIRE II results from other health districts in England.

对首次出现冠状动脉疾病的所有患者进行心脏预防和康复方案的评估。
背景:为首次冠心病临床发作的患者建立了心脏预防和康复(CP&R)计划,并根据英国冠状动脉预防目标评估了1年的结果。方法:患者在参与1年后进行评估,并将结果与同一卫生区随机注册的一半不符合该计划的全科医生(内部参照组)和其他参加EUROASPIRE II调查的英语中心确定的患者(外部参照组)进行比较。结果:318名患者(417例病例中的76%)参加了为期1年的筛查。在参加方案的人中,96/113人(85%)参加了(第一组);所有有资格参加该方案的学生中有152/194(78%)参加了该方案(第2组);166/223(74%)来自同一卫生区接受常规护理的人(第3组——内部参考组)。在EUROASPIRE II调查(第4组-外部参照组)中,筛选了362/744例(58%)患者。随访时的吸烟情况为:第1组为8%,第2组为11%,第3组为13%,第4组为18%。BMI < 25 kg/m的比例分别为29%、25%、32%、18%;BP < 140/90 mmHg 58%, 56%, 49%, 48%;总胆固醇< 5.0 mmol/l 60%, 54%, 43%, 46%;抗血小板治疗88%,87%,86%,81%;受体阻滞剂治疗48%,46%,46%,44%;降脂疗法分别为56% 51% 36% 69%结论:CP&R计划与大多数冠状动脉患者相关,无论是否参加该计划,在同一卫生区域内达到英国联合协会推荐的预防目标。具体而言,较高比例的方案患者达到的胆固醇目标
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信